Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Burkhart DL, Morel KL, Wadosky KM, Labbé DP, Galbo PM, Dalimov Z, et al. Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer. Cancer Prev Res (Phila). 2020;13(12):979-988.

Fajgenbaum DC, Wu D, Goodman A, Wong R, Chadburn A, Nasta S, et al. Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease. Am J Hematol. 2020;95(12):1553-1561.

Tong J, Aksenov SA, Chorost MI, Rodgers WH. Extracranial Meningioma in the Scalp with Concurrent Steatocystoma. Case Rep Pathol. 2020;2020:6539064.

Li N, Inoue K, Sun J, Niu Y, Lalani S, Yallowitz A, et al. Osteoclasts are not a source of SLIT3. Bone Res. 2020;8:11.

Ramalingam P, Poulos MG, Lazzari E, Gutkin MC, Lopez D, Kloss CC, et al. Chronic activation of endothelial MAPK disrupts hematopoiesis via NFKB dependent inflammatory stress reversible by SCGF. Nat Commun. 2020;11(1):666.

Liang H, Wang Q, Wang D, Zheng H, Kalvakolanu DV, Lu H, et al. RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7. Biochem Pharmacol. 2020;180:114118.

Gross MD, Marks LS, Sonn GA, Green DA, Wang GJ, Shoag JE, et al. Variation in Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Outcomes in Asian American Men: A Multicenter Study. J Urol. 2020;203(3):530-536.

Nellis ME, Spinella PC, Tucci M, Stanworth SJ, Steiner ME, Cushing MM, et al. Effect of platelet storage duration on clinical outcomes and incremental platelet change in critically ill children. Transfusion. 2020;60(12):2849-2858.

Luskin MR, Kim AS, Patel SS, Wright K, LeBoeuf NR, Lane AA. Evidence for separate transformation to acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm from a shared ancestral hematopoietic clone. Leuk Lymphoma. 2020;61(9):2258-2261.

Ginter PS, McIntire PJ, Kurtis B, Mirabelli S, Motanagh S, Hoda S, et al. Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity. Mod Pathol. 2020;33(9):1764-1772.